| Literature DB >> 12805207 |
Takashi Kanamori1, Kiyomi Nishimaki, Sadamitsu Asoh, Yoshitomo Ishibashi, Iichiro Takata, Tomoko Kuwabara, Kazunari Taira, Haruyasu Yamaguchi, Shiro Sugihara, Tsuneo Yamazaki, Yasuo Ihara, Kyoko Nakano, Sadayuki Matuda, Shigeo Ohta.
Abstract
Dihydrolipoamide succinyltransferase (DLST) is a subunit enzyme of the alpha-ketoglutarate dehydrogenase complex of the Krebs cycle. While studying how the DLST genotype contributes to the pathogenesis of Alzheimer's disease (AD), we found a novel mRNA that is transcribed starting from intron 7 in the DLST gene. The novel mRNA level in the brain of AD patients was significantly lower than that of controls. The truncated gene product (designated MIRTD) localized to the intermembrane space of mitochondria. To investigate the function of MIRTD, we established human neuroblastoma SH-SY5Y cells expressing a maxizyme, a kind of ribozyme, that specifically digests the MIRTD mRNA. The expression of the maxizyme specifically eliminated the MIRTD protein and the resultant MIRTD-deficient cells exhibited a marked decrease in the amounts of subunits of complexes I and IV of the mitochondrial respiratory chain, resulting in a decline of activity. A pulse-label experiment revealed that the loss of the subunits is a post-translational event. Thus, the DLST gene is bifunctional and MIRTD transcribed from the gene contributes to the biogenesis of the mitochondrial respiratory complexes.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12805207 PMCID: PMC162151 DOI: 10.1093/emboj/cdg299
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598